ANEB - Anebulo Pharmaceuticals, Inc.

QQQ $ 452.83 $ 6.97 (1.56 %)

DIA $ 399.31 $ 3.70 (0.94 %)

SPY $ 529.09 $ 6.48 (1.24 %)

TLT $ 92.14 $ 1.24 (1.36 %)

GLD $ 220.89 $ 2.80 (1.28 %)

Previous Close

$ 2.36

Open

$ 2.30

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.30 - $ 2.43

52 Week Range

$ 1.62 - $ 4.05

Volume

14,979

Average Volume

Market Cap

61.2M

Beta (5Y Monthly)

$ 0.89

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-15-2024	03-31-2024	10-Q
2	02-13-2024	12-31-2023	10-Q
3	11-14-2023	09-30-2023	10-Q
4	09-22-2023	06-30-2023	10-K
5	05-11-2023	03-31-2023	10-Q
6	02-10-2023	12-31-2022	10-Q
7	11-10-2022	09-30-2022	10-Q
8	09-09-2022	06-30-2022	10-K
9	05-11-2022	03-31-2022	10-Q
10	02-11-2022	12-31-2021	10-Q
11	11-12-2021	09-30-2021	10-Q
12	09-22-2021	06-30-2021	10-K
13	06-21-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Anebulo Pharmaceuticals Q3 EPS $(0.06) Bea...
05/15/2024 17:07:44

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate ...

substance-use-disorder-company-narrows-q2-net-loss-reports-progress-on-cannabinoid-intoxication-drug

Substance Use Disorder Company Narrows Q2 ...
02/14/2024 16:37:40

Substance use disorder-focused biopharmaceutical company Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported on Tuesday secon...

Anebulo Pharmaceuticals Announces Richie C...
02/13/2024 21:44:29

Anebulo Pharmaceuticals Q2 EPS $(0.11) Mis...
02/13/2024 21:43:59

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimat...

Anebulo Pharmaceuticals Filed U.S. Patent ...
01/11/2024 11:42:54

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240010617<p> Float: 3,912,399

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
12/21/2023 17:32:34

Anebulo Pharmaceuticals Q1 EPS $(0.10) Bea...
11/14/2023 21:59:46

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate ...

Why ServisFirst Bancshares Shares Are Trad...
10/17/2023 17:42:48

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
10/17/2023 17:31:01

Anebulo Pharmaceuticals Inc's Richie Cunni...
10/06/2023 20:07:31

- Reuters

Benchmark Reiterates Speculative Buy on An...
10/03/2023 15:52:05

Benchmark analyst Robert Wasserman reiterates Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Speculative Buy and maintains $8 ...

On September 26, 2023, Anebulo Pharmaceuti...
09/29/2023 11:23:41

https://www.sec.gov/ix?doc=/Archives/edgar/data/1815974/000149315223034696/form8-k.htm

HC Wainwright & Co. Reiterates Buy on Aneb...
09/25/2023 10:10:31

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy and maintains...

Maxim Group Initiates Coverage On Anebulo ...
09/21/2023 15:49:45

Maxim Group analyst Michael Okunewitch initiates coverage on Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy rating and ann...

Anebulo Pharmaceuticals Q4 EPS $(0.10) Bea...
09/20/2023 20:30:17

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate ...

substance-use-disorder-focused-anebulo-could-be-attractive-acquisition-target-analyst-says

Substance Use Disorder Focused Anebulo Cou...
09/18/2023 17:13:10

H.C.

Benzinga's Top Ratings Upgrades, Downgrade...
09/18/2023 15:00:36

HC Wainwright & Co. Initiates Coverage On ...
09/18/2023 10:33:22

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy ra...

On August 29, Anebulo Pharmaceuticals Inc'...
09/05/2023 12:09:55

- Reuters

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
08/22/2023 13:06:03